NO983512D0 - Midler for behandling og forhindring av AIDS - Google Patents
Midler for behandling og forhindring av AIDSInfo
- Publication number
- NO983512D0 NO983512D0 NO983512A NO983512A NO983512D0 NO 983512 D0 NO983512 D0 NO 983512D0 NO 983512 A NO983512 A NO 983512A NO 983512 A NO983512 A NO 983512A NO 983512 D0 NO983512 D0 NO 983512D0
- Authority
- NO
- Norway
- Prior art keywords
- aids
- prevention
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1482596 | 1996-01-31 | ||
| PCT/JP1997/000218 WO1997027856A1 (fr) | 1996-01-31 | 1997-01-30 | Medicaments pour prevenir ou soigner le sida |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983512D0 true NO983512D0 (no) | 1998-07-30 |
| NO983512L NO983512L (no) | 1998-09-30 |
Family
ID=11871826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983512A NO983512L (no) | 1996-01-31 | 1998-07-30 | Midler for behandling og forhindring av AIDS |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0878194A1 (no) |
| KR (1) | KR19990082201A (no) |
| CN (1) | CN1214632A (no) |
| AU (1) | AU713704B2 (no) |
| CA (1) | CA2245179A1 (no) |
| CZ (1) | CZ238698A3 (no) |
| HU (1) | HUP9901642A3 (no) |
| NO (1) | NO983512L (no) |
| WO (1) | WO1997027856A1 (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998020888A1 (fr) * | 1996-11-08 | 1998-05-22 | Japan Energy Corporation | Medicament contre le sida |
| DE19751948A1 (de) * | 1997-11-24 | 1999-05-27 | Bayer Ag | Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren |
| KR20030019423A (ko) * | 2000-06-13 | 2003-03-06 | 시오노기세이야쿠가부시키가이샤 | 프로페논 유도체를 함유하는 의약 조성물 |
| ES2186550B2 (es) * | 2001-06-27 | 2003-11-16 | Vita Lab | Nuevos derivados de oxazolidinonas como antibacterianos. |
| WO2006089054A1 (en) | 2005-02-16 | 2006-08-24 | Achillion Pharmaceuticals, Inc. | New isothiazoloquinolones and related compounds as anti-infective agents |
| ATE482208T1 (de) | 2004-03-10 | 2010-10-15 | Us Of America Represented By T | Chinolin-4-one als inhibitoren der retroviralen integrase zur behandlung von hiv, aids und aids- related complex (arc) |
| US7659399B2 (en) | 2005-01-05 | 2010-02-09 | Achillion Pharmaceuticals, Inc. | 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents |
| WO2006084053A1 (en) | 2005-02-02 | 2006-08-10 | Achillion Pharmaceuticals, Inc. | 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents |
| AU2006272571B2 (en) | 2005-07-27 | 2012-03-08 | Achillion Pharmaceuticals, Inc. | 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents |
| US8598354B2 (en) | 2008-12-05 | 2013-12-03 | University Of South Florida | Compounds having antiparasitic or anti-infectious activity |
| EP2370411A4 (en) * | 2008-12-05 | 2012-10-24 | Univ Oregon Health & Science | COMPOUNDS HAVING ANTIPARASITIC OR ANTI-INFECTIOUS ACTIVITY |
| KR20120004510A (ko) | 2009-04-03 | 2012-01-12 | 아칠리온 파르마세우티칼스 인코포레이티드 | 항감염제로서의 하이드록시티에노퀴놀론 및 관련 화합물 |
| WO2015005429A1 (ja) * | 2013-07-10 | 2015-01-15 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 新規ｐｄｅ４阻害剤 |
| WO2015078799A1 (en) * | 2013-11-27 | 2015-06-04 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| CN103961684B (zh) * | 2014-05-23 | 2016-05-18 | 滨州医学院 | 沙奎拉韦在制备预防或治疗肺纤维化的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2993316B2 (ja) * | 1992-05-27 | 1999-12-20 | 宇部興産株式会社 | アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤 |
| JPH08311024A (ja) * | 1995-03-15 | 1996-11-26 | Sankyo Co Ltd | Ａｈｐｂａ構造含有ジペプチド化合物 |
-
1997
- 1997-01-30 CA CA002245179A patent/CA2245179A1/en not_active Abandoned
- 1997-01-30 CZ CZ982386A patent/CZ238698A3/cs unknown
- 1997-01-30 AU AU15564/97A patent/AU713704B2/en not_active Ceased
- 1997-01-30 WO PCT/JP1997/000218 patent/WO1997027856A1/ja not_active Application Discontinuation
- 1997-01-30 HU HU9901642A patent/HUP9901642A3/hu unknown
- 1997-01-30 KR KR1019980705927A patent/KR19990082201A/ko not_active Application Discontinuation
- 1997-01-30 EP EP97901785A patent/EP0878194A1/en not_active Withdrawn
- 1997-01-30 CN CN97193373A patent/CN1214632A/zh active Pending
-
1998
- 1998-07-30 NO NO983512A patent/NO983512L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9901642A2 (hu) | 1999-09-28 |
| KR19990082201A (ko) | 1999-11-25 |
| EP0878194A1 (en) | 1998-11-18 |
| HUP9901642A3 (en) | 2000-07-28 |
| CA2245179A1 (en) | 1997-08-07 |
| CZ238698A3 (cs) | 1998-12-16 |
| AU713704B2 (en) | 1999-12-09 |
| AU1556497A (en) | 1997-08-22 |
| CN1214632A (zh) | 1999-04-21 |
| WO1997027856A1 (fr) | 1997-08-07 |
| NO983512L (no) | 1998-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO992641D0 (no) | Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer | |
| NO971015L (no) | Forbindelser og metoder for behandling av cancer | |
| NO991700D0 (no) | Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer | |
| NO994778D0 (no) | FremgangsmÕter og sammensetninger for behandling av tarmbetennelse | |
| NO986052D0 (no) | Antikonvulsive derivater for behandling av fedme | |
| NO991381D0 (no) | Kombinasjonsterapi for behandling av psykoser | |
| NO20002784L (no) | Forhindring og behandling av amyloidogen sykdom | |
| NO20004098D0 (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
| NO983266D0 (no) | Distribuert Behandling | |
| FI964874A (fi) | Vihannesten käsittely | |
| PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
| NO985484L (no) | FremgangsmÕte og preparat for behandling og forhindring av hyperurikemi | |
| NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| NO983512D0 (no) | Midler for behandling og forhindring av AIDS | |
| NO20014674D0 (no) | Fremgangsmåte for behandling av neurologiske og neuropsykiatriske forstyrrelser | |
| AU1697197A (en) | Immunoconjugate for the treatment of aids | |
| NO983263D0 (no) | Distribuert behandling | |
| NO961226L (no) | Blandinger for forebyggelse og behandling av viralinduserte tumorer | |
| NO20001758D0 (no) | Fremgangsmåter og blandinger for behandling av leddgikt | |
| NO984432D0 (no) | FremgangsmÕte for behandling av migrenesmerte | |
| NO985068L (no) | Vaksiner for behandling av lymfom og leukemi | |
| NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
| DK0918521T3 (da) | Formulering til behandling og/eller forebyggelse af demens | |
| NO984190D0 (no) | Fremgangsmåte for behandling av insomnia | |
| KR940002718U (ko) | 치질예방 및 치료기 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |